CD serologic surveillance with tTG-IgA, with or without EMA-IgA, may not be sufficient to monitor CD status in children with CD and EGID, and further consideration should be made regarding repeat duodenal biopsies to assess mucosal healing. Here, TGM2 is linked to eosinophilic gastrointestinal disease.